All posts by student

23andMe to launch study exploring role of genetics in depression, bipolar disorders – MobiHealthNews

Personal genetics company 23andMe will be teaming up with the Milken Institute, a think tank, and pharmaceutical company Lundbeck to drive enrollment for a genetic study designed to grasp the underlying biology of major depressive and bipolar disorders.The study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes -- such as attention, decision-making and visual perception -- in individuals who live with these serious mental health conditions.In the United States alone, more than 16 million people are living with a major depressive disorder, according to the National Institute of Mental Health, while nearly 6 million Americans suffer from bipolar disorder. The causes of these disorders are largely unknown, but there are clues: research from the National Alliance on Mental Illness, for example, suggests major depressive and bipolar disorders are caused by a combination of genetic, biological and environmental factors. Other studies back up the hypothesis that theres a genetic component involved.In August 2016 a landmark study was published by 23andMe, Massachusetts General Hospital and Pfizer, detailing the scientific connection between genetics and depression, said Anna Faaborg, Research Communities manager at 23andMe. In that study, we identified 15 genetic regions that were linked to depression. However, even with recent scientific advancements, more research is needed to help accelerate our understanding of these conditions and drive medical discoveries forward. We want to expand on the genetic component, looking at additional phenotypic factors of depression and bipolar, to hopefully gain a more holistic understanding of these diseases.To conduct this research, 23andMe intends to recruit 15,000 people with major depressive disorder and 10,000 people with bipolar disorder. The study is open to anyone aged 18 to 50 who has been diagnosed with major depressive disorder or bipolar disorder, has been prescribed medication to treat his/her condition, lives in the United States and has access to the internet through a desktop or laptop computer.This study is the first to combine data from genetics, cognitive tests and online surveys at this scale, said Faaborg. The hope is to gain a greater understanding of how genetics is related to brain functions such as attention, decision-making and reaction time. This knowledge of the biological underpinnings of disease could ultimately inform the development of novel, disease-modifying therapies.As part of the study, consenting participants will receive the 23andMe Personal Genome Service at no cost, including more than 75 personalized genetic reports about their health, traits and ancestry. Theyll provide a saliva sample for DNA genotyping, and then complete nine monthly online cognitive assessment sessions each lasting between 10-30 minutes. Participants de-identified data will be analyzed for clues as to how genetics and environmental factors combine to impact their brain function and behavior.Participants will receive regular updates about the progress of the study via email or newsletters. If there is a publishable result from the study, 23andMe will publish that information in a peer-reviewed journal and make it open access for all those interested in learning about the findings.At this early stage, we cannot anticipate where the data will lead us or exactly which analyses will be performed, said Faaborg.The study will build on 23andMes body of research in mood disorders. Its launch furthers the companys genetic discovery efforts with research collaborations already established in Parkinsons disease, lupus and inflammatory bowel disease, and more than 75 peer-reviewed papers published in scientific journals

Go here to read the rest:
23andMe to launch study exploring role of genetics in depression, bipolar disorders - MobiHealthNews

Neuroscience Graduate Program | School of Medicine …

Neuroscience Graduate Program

The Neuroscience Training Program at the CU School of Medicine provides multidisciplinary training covering the breadth of neurobiology, from neuronal gene regulation to the development, structure, and function of the nervous system.

Students receive training in cellular and molecular neurobiology, neural development, neuropharmacology, and biochemistry, as well as hands-on training in a variety of state-of-the-art laboratory techniques.

Read the rest here:
Neuroscience Graduate Program | School of Medicine ...

Shire may spin off Neuroscience franchise, upgrades guidance – Times of India

(Adds Neuroscience details)

LONDON, Aug 3 (Reuters) - Shire said it was exploring strategic options for its hyperactive drugs business, including a possible independent public listing, as the London-listed pharmaceutical maker upgraded its full-year earnings forecast on Thursday.

Shire, which reported 7 percent growth in second-quarter product sales, said it expected to complete a strategic review of its Neuroscience franchise by the end of the year.

"As part of the board's ongoing commitment to optimise Shire's portfolio and strategic focus, Shire is assessing strategic options for our Neuroscience franchise to derive even greater value from this franchise," it said.

The company upgraded the midpoint of its full-year forecast by 10 cents to $15 after stronger-than-expected costs savings from its acquisition of haemophilia specialist Baxalta last year.

It reported second-quarter revenue of $3.75 billion and non GAAP earnings per ADS of $3.73, up 11 percent and beating a market forecast of $3.60.

Shire shares were trading up 3.4 percent at 4,341 pence at 1126 GMT.

(Reporting by Paul Sandle; editing by Jason Neely)

See original here:
Shire may spin off Neuroscience franchise, upgrades guidance - Times of India

Rare Conjoined Bat Twins Found in Brazil – Live Science

The corpses of rare conjoined bats found in Brazil have given scientists a closer look into a phenomenon that has only ever been recorded twice before.

When Marcelo Rodrigues Nogueira, a postdoctoral researcher in biology at the State University of Northern Rio de Janeiro first saw the bat twins, he was "completely astonished," he wrote in an email to Live Science. "I have handled many bats [in my career], some with very impressive morphological characters (and bats are very special in this respect!), but none [were as] surprising as these twins." [See Photos of the Rare Conjoined Bats Found in Brazil]

Only two other pairs of conjoined bat twins have been reported in the scientific literature, one in 1969 and another in 2015.

Although it's not known exactly what causes identical twins to be conjoined, the phenomenon is known to occur when a fertilized egg splits too late. If an egg splits four to five days after being fertilized, two separate identical twins will form. If, however, the splitting doesn't occur until 13 to 15 days after fertilization, the fertilized egg will only separate partially, and the twins will be conjoined.

The researchers first became aware of the conjoined bats after the animals were donated to the Laboratory of Mastozoology at the Rural Federal University of Rio de Janeiro. No one from Nogueira's team, which includes embryologists Nadja Lima Pinheiro and Adriana Ventura from the Area of Embryology at the Rural Federal University of Rio de Janeiro, saw the twins right when they were found. Because of this, the scientists, aren't certain if the twins were stillborn or if they had died shortly after birth.

These conjoined bat twins, found under a mango tree in southeastern Brazil in 2001, were either stillborn or died shortly after birth.

The bats, found under a mango tree in southeastern Brazil in 2001, are dicephalic parapagus conjoined twins, which means they're oriented side by side with their whole trunks conjoined. X-rays revealed that the twins' spines form a "Y" shape, with two separate columns of vertebrae branching off at the lower back. Ultrasound images also revealed two hearts of equal size that researchers suspect are separate, the scientists said.

Since most bats have only one pup per litter, finding even nonconjoined bat twins is rare. In the five years Daniel Urban, a postdoctoral research associate in evolutionary developmental biology at the University of Illinois at Urbana-Champaign, has been studying bats, he's only ever seen a single pup flying around or hanging onto its mother, he told Live Science. Urban was the lead author of the 2015 study on conjoined bat twins that was published in the journal Acta Chiropterologica.

It's even harder to find bat twins that are conjoined. But this doesn't mean conjoined twins are rarer in bats than in any other mammals, according to Scott Pedersen, a professor of biology and microbiology at South Dakota State University, who was not involved in the new study. It's just that humans find out about conjoined bats less often than they find out about other conjoined animals, he told Live Science in an email. [Image Gallery: Evolution's Most Extreme Mammals]

Even if conjoined bats are alive when they are born, it's likely that they'll die soon after, because their bodies can't sustain them, Pedersen said. Bats also tend to live in places humans aren't located, which means even if a person were to venture into a bat's domain, the person would need to find the conjoined bats before they degraded or were scavenged.

This is only made more unlikely by the fact that bats are nocturnal, said Urban. If a mother gives birth to conjoined bats during the day, it will likely be in a protected roost, which means people wouldn't see them. She may give birth while she's out in the open, but that would occur only at night, when the twins would be obscured by darkness, Urban said.

"If you combine all these factors together, it's amazing we even have any [conjoined bat twins]," he added.

This X-ray shows that the spines of these conjoined bat twins are joined at their lower backs.

Although little is known about the organs of the recently discovered conjoined bat twins, the researchers have opted not to use any invasive methods to further investigate the animals' bodies.

"It's so rare and precious that you find something like this, you don't want to do any type of destructive sampling to look further. You're, of course, very curious about it, but they're a one-shot deal so, for the most part, they're held onto until the future where a newer technology will allow us to pursue it further without completely damaging what we already have," Urban said.

The new study was published online June 16 in the journal Anatomia Histologia Embryologia.

Original article on Live Science.

Read the original:
Rare Conjoined Bat Twins Found in Brazil - Live Science

Editor’s Note: Anatomy of a political meltdown – Connect Savannah.com

THE CIRCUS-LIKE atmosphere currently dominating the Trump White House seems to be getting some local competition, if last weeks wild and woolly political news at home is any indication.

Savannah politics has a seedy and ugly underbelly. That we already knew.

The ongoing chaos surrounding Alderman Tony Thomas, for example, is just one episode of the long and messy reality TV series we call local politics.

Tensions over the 2018 Congressional midterm elections still a year and a half away! have been running high here since last Februarys town hall meeting with Congressman Buddy Carter.

That event at the Armstrong Center garnered national coverage for the raucous intensity of opposition to the Republican incumbent, who represents Chatham County in Georgias First Congressional District.

But turns out that wild affair was just a prologue.

The latest round of recrimination doesnt involve Buddy Carter so much as it does bizarre internal strife in the Democratic Party ranks.

Or maybe not so much in the actual party ranks after all?

In this issue you will find Jessica Leigh Leboss interview with Lisa Ring, one of the candidates who has announced a bid for the Democratic nomination in order to challenge Carter in November 2018.

As of this writing, Lisa could have one less opponent to worry about.

In the prior issue we ran my interview with another Democratic candidate, Steve Jarvis, whose campaign immediately melted down in ugly fashion even by Savannah standards.

The trouble had already begun before Jarviss official announcement last Thursday (which perhaps symbolically took place during a heavy thunderstorm).

Jarviss admittedly quite conservative positions, as he openly stated in our interview, immediately drew fire from local Democratic activists, who wondered why someone who echoes Donald Trump on some issues would bother running as a Democrat.

Unflattering interactions from campaign staff with people who showed up at the Thursday announcement triggered further hard feelings.

By this past Saturday, things had reached a fever pitch, as internet sleuths discovered that Jarvis had apparently flirted with political runs in his home of Bryan County before, only as a Republican, and seemingly under a slightly different name.

Jarviss former campaign manager Michael Shortt was defending the candidate as late as Saturday afternoon against charges he had run as a Republican.

On Jarviss now-defunct Facebook page, the candidate issued a statement containing the following garbled response:

Several years ago, friends in Bryan County (which is 92% Republican) did try to draft me to run, I declined. If they filled out any forms, its news to me. But even if they did, and if I had, which I didnt, and even if I had been an R instead of a D. So what?

The statement then went on to try and make the case that many folks with Republican leanings citing Hillary Clinton and Elizabeth Warren as examples went on to run as Democrats.

As you might expect, the campaigns response only added fuel to the fire, and made a bad situation that much worse.

Negative comments on Jarviss Facebook page came in fast and furious, with many deleted as fast as they were posted, some with parting shots to the commenters calling them socialists.

By Monday morning the Facebook page was no more.

About an hour later the campaign website itself followed it into oblivion, and was then back up.

By noon Monday, Shortt had officially jumped ship, and he issued this terse statement to the media:

I and my businesses (Tandem, Carbon Media) are no longer representing or affiliated with the Congressional campaign of Steve Jarvis (Bernard Stefan Jarvis) for philosophical and professional reasons.

Meanwhile, I found myself on the receiving end of various personal attacks from a few local political types just for running the Jarvis interview at all though we made it clear that we would be interviewing as many candidates in the race as possible in order to keep things fair.

There seems to be a minor misconception among some that we are only "supposed" to talk to certain types of candidates. (We are endeavoring to interview another candidate for the First District, Adam Bridges, as soon as we can. So get your poison pens ready!)

Savannahs unofficial motto seems to be, No good deed goes unpunished. But we dont apologize for doing our jobs and interviewing people running for office as much and as often as we can.

An interview isnt the same as an endorsement, though apparently some folks dont agree.

The way I see it, our interview was a public service in that it gave readers a chance to see Jarviss policy positions, in his own words, for what they were basically conservative.

Jarvis may have misrepresented a few things, but apparently he was telling the truth about his conservative positions.

Its a free country, and what you do with that information is up to you. Which I guess includes coming up with unhinged conspiracy theories about the hidden evil agenda of the local alt-weekly editor.

All that said, the First District is a very conservative one, and running on a conservative platform is far from the craziest idea if you want to represent it in Congress.

In the meantime, Buddy Carter is planning to hold another town hall meeting, this one on Thursday, Aug. 10, at Bible Baptist School in Savannah.

Except this time, it is a ticketed event. Free to attend, but you have to sign up first.

We are using a ticketing system to ensure constituents of the First District are able to attend town hall meetings in an orderly fashion, says Congressman Carters office.

Will limiting admission make things more orderly?

Or will it invite even more opposition?

Will the next Buddy Carter Town Hall be a circus like the last one?

And will the media be blamed for everything that goes wrong?

Stay tuned for the next episode!

Its must-see stuff, even though some players so far have clearly not been ready for prime time.

cs

See more here:
Editor's Note: Anatomy of a political meltdown - Connect Savannah.com

Seattle Genetics buys biotech factory in Bothell – The Seattle Times

Seattle Genetics has agreed to buy the Bristol-Myers Squibb manufacturing plant in Bothell for $43.3 million, giving the biotech the ability to make its own bulk quantities of antibodies for treating cancer.

Special to The Seattle Times

Seattle Genetics has agreed to buy the Bristol-Myers Squibb manufacturing plant in Bothell for $43.3 million, giving the biotech the ability to make its own bulk quantities of antibodies for treating cancer.

Until now the Bothell-based company has relied entirely on contract manufacturers.

Seattle Genetics will continue to use contract manufacturers because of its international footprint, but this will give us our first manufacturing facility that we actually own, said Clay Siegall, the companys chairman, president and CEO.

About 75 people work at the Bristol-Myers facility on Bothells Monte Villa Parkway. Our hope is to keep the team intact, Siegall said Tuesday.

Seattle Genetics now leases seven buildings in its Canyon Park campus, which is about 20 blocks north of the new property.

The company paid $17.8 million for the land and the building, and an additional $25.5 million for the equipment and the building improvements, Siegall said. The deal gives Seattle Genetics ownership of a fully staffed and operating plant that requires little modification.

Were really excited about this, he said. It gives us the ability to control more of our supply chain.

The company will use the plant to make vials of antibodies that are used to treat cancers. Its leading product, Advetris, is now approved for treating patients with two kinds of lymphomas.

Revenue at Seattle Genetics has climbed steadily in the last five years, but so have the losses. Last year the company lost $140million on total revenue of $418 million, according to company reports.

The sale could set the stage for Bristol-Myers exit from the region.

In December the New York-based company said it would not renew a lease that expires in 2019 for its ZymoGenetics unit on Seattles Lake Union. Bristol-Meyers bought the ZymoGenetics research arm in the former Seattle City Light Steam Plant, as well as the production plant now sold to Seattle Genetics, in 2010 for $885 million.

Originally posted here:
Seattle Genetics buys biotech factory in Bothell - The Seattle Times

Irvine-based CombiMatrix in $33 million merger deal with Bay Area genetics firm – OCRegister

A medical technologist at CombiMatrix examines live tissue looking for fetal cells to analyze. (File Photo)

From left, medical technologists Lilybeth Wilkens, Meg Purayil, and Catherine Marte work on live samples of tissue at CombiMatrix, a genetic testing lab in Irvine. (File Photo)

Catherine Marte works on live samples of tissue at CombiMatrix, a genetic testing lab in Irvine. (File Photo)

Chief Executive Mark McDonough stands in the lobby of his company, CombiMatrix Corp., in Irvine. The company hopes its testing method will be used to analyze cases of women whove had multiple miscarriages. (File Photo)

Irvine-based CombiMatrix Corp. has agreed to be acquired in an all-stock merger by San Francisco-based Invitae Corp. for $33 million.

The deal between two genetic biotech firms is subject to approval by CombiMatrixs stockholders and regulatory agencies.

CombiMatrix is a molecular diagnostics company that studies theremains of lost pregnancies, extracting DNA that is analyzed to uncover genetic abnormalities that can help explain why the women who gave the samples have had multiple miscarriages. It also does pre-implantation genetic diagnostics and screening, prenatal diagnosis andDNA-based testing forgenetic abnormalities.

In 2014, the companys chief executive, a former Navy navigator, told the Register the companys methods would soon become the standards for analyzing pregnancy loss and prenatal testing.

Merging with Invitae, which also specializes in genetic material and hereditary disorders, should expand the scope of CombiMatrixs reach.

By coming together with Invitae, we believe we can synergistically combine their scale, technology and expertise with the CombiMatrix product offering, human capital and sales channels to achieve even greater success in the future for the company and our shareholders, Mark McDonough, president and chief executive officer of CombiMatrix, said in a statement.

CombiMatrix will be a wholly-owned subsidiary of Invitae, according to documents filed with the Securities and Exchange Commission.

The company declined to provide any information not found in SEC documents, such as potential job impacts or executive changes.

For many people, preparing to have a child is their introduction to the power of genetics to inform health decisions, Sean George, chief executive officer of Invitae, said in a statement. The combination of Invitae and CombiMatrix will expand our ability to provide actionable answers to the complex questions that can arise when starting a family.

Testing has become more common as women have babies later in life. In 2016, theaverage age when women have their first child was 28. In 1970, it was 24.6, according to the CDC.

McDonough, in 2014, said he saw a market of up to $200 million a year for so called microarray prenatal testing and a$330 million marketfor recurrent pregnancy loss.

CombiMatrixspun off of Newport Beach-basedAcacia Research Corp. in 2007. It got its start supplyinglaboratories conducting microarray tests with biotech tools before founding a genetic testing lab.

In 2010, it moved to Irvine from Seattle.

Invitaeon Monday said it is also acquiring Cambridge, Mass.-based Good Start Genetics, another pregnancy-related molecular diagnostics company that specializes in preimplantation and carrier screening.

Read the rest here:
Irvine-based CombiMatrix in $33 million merger deal with Bay Area genetics firm - OCRegister

Neuroscience in the Land of the Rising Sun – PLoS Blogs (blog)

Japan is like no other country in the world, fusing the ancient and the modern seamlessly. As soon as I landed in Tokyo, I noted the presence of a girl in a kimono against the scintillating neon billboards and endless flow of salarymen. Dressed in a sakura print and wooden sandals, she exhibited a timeless beauty.

The Japanese capital delivers an incredible array of experiences, from festivals at shrines to crane games at arcades. Opportunities for scientific growth are also among the offerings in Japan. This summer, I had the chanceto attend a weeklong lecture course in the greater Tokyo area called, Exploring and Emulating the Brain, organized and held by the RIKEN Brain Science Institute. In recapping my trip, I hope to make apparent the benefits of exploring your field in a new place.

My First Day

As I sat down for breakfast on the first day of the program, I was overcome with anxiety. Surrounded by strangers on the opposite side of the world, I moved to the rightmost corner of the lobby. I sipped on miso soup as I eavesdropped on awkward conversations about the brain and jetlag. Choosing not to socialize, I walked to the campus alone.

Too shy to initiate conversation, I sat in the lecture hall reading The New Yorker. Someone soon approached me holding out his ID badge. I put away my iPad and remembered that my primary goal for this course was to engage with fellow program participants. As aspiring young scientists, we build our professional networks and create job opportunities through communication and collaboration. Although it may not feel like it in the moment, an uncomfortable situation can help you grow as a person. The challenge is to get past that initial discomfort to learn something new. I was able to experience that this summer through the RIKEN BSI Summer Program.

Course Content

Alongside my peers, I was able to learn from the noted neuroscientists in attendance. Each lecture was an hour and a half, which enabled professors to share their findings in great detail. Andrew Zalesky of the University of Melbourne, Australia gave the first of fifteen lectures. He presented on neural connectomics, which is the production of comprehensive structural maps. Many researchers question the usefulness of connectomes. Its like a road map that tells you where cars can drive, but does not tell you when or where cars are actually driving, says Oliver Hobert of Columbia University. However, Zalesky elegantly argued that connectomics revealed topological properties shared across scales and species. One such property is hub nodes, which are brain regions that integrate information to enable efficient signaling.

As neuroscience details the anatomy and activity of the brain, artificial intelligence seeks to develop a non-biological path to intelligence. In a discussion panel on neuroscience and artificial intelligence, we heard from prominent researchers such as Yoshua Bengio, Shun-ichi Amari, and Andrew Zalesky. My takeaway was that artificial intelligence is not the equal of natural intelligence in most important tasks for human cognition such as vision and natural language processing. However, this is not to say that artificial intelligence wont ultimately achieve principles of natural intelligence.

Through this course, I learned how experimental and theoretical research could benefit each other. Speakers such as Terrence Sejnowski created a model based on experimental data to generate hypotheses. His computational background enabled him to bring new approaches to problems that had been accepted in sleep research. With data-driven predictions, perhaps experimental neuroscience can accelerate more rapidly and we can come closer to understanding what makes us human.

Conclusion

My greatest takeaway from this course was the incredible people I met. I had the opportunityto interact withpeople from all over the world aspiring to become scientists. Through conversations with graduate students and post-doctoral researchers, I was also able to learn about life as a scientist in Japan.

After each day of lectures, we set out to explore Tokyo in the evenings and participated in the optional Tokyo tour at the conclusion of the program. From feeling at home in the hipster district of Shimokitazawa to being overwhelmed by the pachinko parlors of Akihabara, it was incredibly rewarding to experience Tokyo in all its flavors. The RIKEN Brain Science Institute Summer Program surpassed my expectations and I highly recommend it.I encourage fellow early career researchers to immerse themselves in a new culture while pursuing science.

References

Salaryman. (2017, July 13). Retrieved July 31, 2017, from https://en.wikipedia.org/wiki/Salaryman

RIKEN Brain Science Institute Summer Programs Poster,http://www.brain.riken.jp/en/asset/img/summer/Poster2017.pdf

Daniel Mediati, Science is the Name but Collaboration is the Game, April 14, 2017. http://blogs.plos.org/thestudentblog/2017/04/14/science-is-the-name-but-collaboration-is-the-game/.

RIKEN Brain Science Institute,http://www.brain.riken.jp/en/.

Dr. Andrew Zalesky, People: Department of Electrical and Electronic Engineering, University of Melbourne. Retrieved July 31, 2017, from http://www.ee.unimelb.edu.au/people/staff.php?person_ID=24599

PLOS One Connectomicshttp://journals.plos.org/plosone/browse/connectomics

Oliver Hobert Lab Website, Columbia University,http://hobertlab.org/.

YoshuaBengio. Retrieved July 31, 2017, from http://www.iro.umontreal.ca/~bengioy/yoshua_en/

Shun-ichi Amari, RIKEN Brain Science Institute,http://www.brain.riken.jp/labs/mns/amari/home-E.html.

The Sejnowski Lab,http://cnl.salk.edu/.

Photographs provided by the author.

Here is the original post:
Neuroscience in the Land of the Rising Sun - PLoS Blogs (blog)

Brown to lead ‘NeuroNex’ center for creating bioluminescent neuroscience tools – Medical Xpress

Four tubes contain the ingredients that produce bioluminescence: Coelenterazine appears buoyant, swirling as it interacts with luciferase. The three tubes on the right also contain different colored fluorescent proteins attached to the luciferase which, as a result, emit cyan, green or yellow light. Credit: Nathan Shaner

With up to $9.2 million in funding over five years from the National Science Foundation, Brown University will lead a national center dedicated to developing and disseminating new tools based on giving nervous system cells the ability to make and respond to light. Neuroscientists could use the tools to uniquely manipulate and observe the circuitry of the brain in a variety of model organisms.

The new "NeuroNex Technology Hub" is a collaboration of labs at Brown, Central Michigan University and the Scintillon Institute. The team's charge is to invent, improve upon and combine several unique bioengineering technologies to create new research capabilities. They will then make their advances rapidly, easily and freely available to the global scientific community.

"Through NeuroNex, we want to enable all scientists to take advantage of the best tools," said principal investigator Christopher Moore, a professor of neuroscience at Brown and associate director of the Brown Institute for Brain Science (BIBS). "There is a real problem in science of certain inequities in access. The idea is to systemically address that."

The center's other leaders are Diane Lipscombe, a Brown professor of neuroscience and BIBS director, Ute Hochgeschwender, a professor at CMU, and Scintillon researcher Nathan Shaner. Justine Allen, a graduate of Brown's doctoral program in neuroscience, will serve as the center's administrative director.

In addition to creating the new tools for the scientific community, the team intends to turn its research, which combines elements of biology, chemistry, physics and engineering, into a curriculum to engage and educate high school students.

Enlightened brains

The research has its roots in bioluminescence, the natural ability of cells to make light, as fireflies and many aquatic animals do. Moore, Lipscombe, Hochgeschwender and Shaner have already been working together to engineer bioluminescence into a variety of cells, including neurons, in a project supported in its early stages by the W. M. Keck Foundation. Their work includes making light production contingent on an influx of calcium, a typical means that neurons employ to trigger each other into action. They've also created a brighter form of bioluminescence with proteins they call LumiCaMPsins. In the new project, they will continue to work to create even brighter calcium-modulated bioluminescence in neurons.

The team combines this engineered bioluminescence with optogenetics, a decade-old technology in which distinct types of neurons can be genetically altered to turn on and off in response to light. Currently, optogenetics requires scientists to inject light into the brain of an animal via fiber optics at times and places they hope are appropriate for their work. But when bioluminescence and optogenetics are combined (the scientists call this "BL-OG"), cells can illuminate and regulate themselves when an event, such as a particular behavior, spawns an uptick in calcium. Cells programmed in this way, Moore said, can automatically respond to experimental conditions without the scientists having to manually stimulate them.

As a hypothetical example of how meaningful that could be, Moore posits a clinical application of the technology (should it become applicable in humans in the future). Imagine that a person with epilepsy is about to have a seizure, he says. As neurons with BL-OG begin to become overly activated by surging calcium levels, they could emit light that would optogenetically override that hyperactivity, automatically dampening out the seizure before it can get started.

Beyond programming cells to regulate their own activity, the team also hopes to develop ways to make cells stimulate each other with light. Such "inter-luminescence" would allow scientists to program and observe calcium-modulated dynamics in whole circuits, Moore said.

Moreover, the group also plans to create new imaging tools. Using a variety of fluorescent molecules, including some that Shaner helped to pioneer, scientists today can make cells glow in response to experimental events, Moore said, but that requires shining a stimulating light on them that can damage tissue and adds a source of noise as that incoming light scatters. Bioluminescence allows cells to glow on cue without that external stimulation, reducing the possibility of damage and reducing a source of scatter. Implanted imaging devices could also be lighter and use less power if they don't have to produce stimulating light.

Moore said one of the reasons the collaborators are excited to share what they are finding is that there is much more room for innovation with the technology than they can fill on their own.

"In our own experience as a cloud of labs working on this stuff, the list of things we want to create to make the world better is getting bigger and bigger," Moore said. "We want to enable the whole field to let them all go after it."

Enlightening minds

As they develop new tools and techniques, the team will employ several means to disseminate them, Moore said. They will produce a website with downloadable experimental protocols, genetic sequences and other documentation and will send "emissaries" to teach other research groups. They will annual hold workshops for visiting scientists to come together, generate and discuss ideas, form new collaborations and learn how to use the new technologies.

"Bring all your students and all your postdocs, and inspire them to take a few of these research questions," Allen said. "Take those home and let this grow."

Moore noted that the collaborators have a strong ethic of such openness. He serves on the board of OpenEphys, an open-source initiative to promote sharing of electrophysiology tools started by two former graduate students in his lab. Lipscombe, Hochgeschwender and Shaner have also openly shared tools and technologies with the research community before, he said.

In addition to teaching other scientists, Moore said, the collaboration will also teach students at several different levels. They plan to hold a weeklong "intensive practicum" course for undergraduate students every spring at the Marine Biological Laboratory in Woods Hole, Mass., to which they encourage applications from students underrepresented in science, technology, engineering and mathematics. They will also create and teach courses in local Providence high schools that already work with the Brown Brain Bee. And finally, Moore said they hope to create an online version of the curriculum for other schools nationwide.

Explore further: Revolutionizing the revolutionary technology of optogenetics

View original post here:
Brown to lead 'NeuroNex' center for creating bioluminescent neuroscience tools - Medical Xpress

Salk scientist Reuben Shaw wins NCI Outstanding Investigator Award – News-Medical.net

August 1, 2017

Salk Professor Reuben Shaw has received the National Cancer Institute (NCI) Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk's Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work. The award is granted, according to the NCI website, to innovative cancer researchers with outstanding records of productivity to allow them to take greater risks and be more adventurous in their research.

"It was extremely exciting to get this award as it will provide my lab both the resources and the stability for our ongoing efforts," says Shaw, who is also the director of the Salk Cancer Center, which is one of just seven NCI-designated Basic Research Cancer Centers in the country.

Shaw's research focuses on cancer metabolism: how metabolic pathways are altered in cancer and play a role in the origins and progression of the disease. While investigating one of the most commonly mutated genes in lung cancer, Shaw discovered an energy-sensing pathway that shuts down cell growth and reprograms metabolism when nutrients are scarce. This energy-sensing "starvation" pathway suggests an unexpected and direct link between metabolic pathways and cancer.

His lab went on to molecularly decode a number of new components of this cellular starvation pathway, which connects nutrition and exercise to suppression of both cancer and diabetes. From this work, the lab's studies have led to the discovery of new therapies for cancer and metabolic diseases. Recently, Shaw's lab showed that using a small molecule to target one of the pathways that cells use to synthesize fat can starve cancer cells of the building blocks they need to grow. Previously, he published work showing how different cancers are sensitive to different sources of cellular energy and how a common, deadly lung cancer spreads.

"Reuben's pioneering research points to potential new ways to unravel a variety of cancers and target the disease precisely and effectively," says Salk President Elizabeth Blackburn. "We are delighted that his work is being recognized with this award."

Some of the Shaw lab's ongoing efforts have involved identifying unique metabolic features of tumor cells. Shaw wants to better define different genetic subsets of lung cancer by these features and pinpoint ways to treat them based on that knowledge. "We want to identify the Achilles heel of each tumor subset," he says. "We're not going to treat all lung cancers the same way but rather tailor our attacks based on unique properties of each subtype of cancer. This should yield more effective treatments for all forms of cancer. Our work decoding new components of the energy-sensing pathway has also led to new therapeutic targets for many difference forms of cancer, which alter these same pathways through many different mechanisms."

Shaw is the second Salk scientist in the award's three-year history to be named an NCI Outstanding Investigator. The other is Geoffrey Wahl, a professor in the Gene Expression Laboratory.

a9e7f880-a833-4ae8-9ac9-ddce025dbab4|0|.0

Posted in: Medical Research News | Medical Condition News

Tags: Cancer, Cell, Diabetes, Exercise, Gene, Gene Expression, Genes, Genetic, Genetics, Immunology, Laboratory, Lung Cancer, Metabolism, Molecule, Neuroscience, Nutrients, Nutrition, Tumor

Read more here:
Salk scientist Reuben Shaw wins NCI Outstanding Investigator Award - News-Medical.net